Jennifer S. Roach

Development of Biologic Markers of Response and Assessment of Antiangiogenic Activity in a Clinical Trial of Human Recombinant Endostatin

Roy S. Herbst, Nizar A. Mullani, Darren W. Davis et al. · Journal of Clinical Oncology · 2002 · 180 citations

Medicine, Oncology, Pharmacology +17

Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats.

Péter Nagy, Ritva P. Evarts, E R Marsden et al. · PubMed · 1988 · 65 citations

Medicine, Cell Biology, Oncology +15

Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

Jennifer Tseng, Bonnie S. Glisson, Fadlo R. Khuri et al. · Cancer · 2001 · 48 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Assessment of Antiangiogenic Effect Using ^99m Tc-EC-Endostatin

David J. Yang, Kil-Dong Kim, Naomi R. Schechter et al. · Cancer Biotherapy and Radiopharmaceuticals · 2002 · 45 citations

Medicine, Oncology, Pharmacology +16

Targeted therapy against human lung cancer in nude mice by high-affinity recombinant antimesothelin single-chain Fv immunotoxin.

Dominic Fan, Seiji Yano, Hisashi Shinohara et al. · PubMed · 2002 · 42 citations

Medicine, Oncology, Pharmacology +6